Novalis Biotech invests in Rarity Bioscience’s
ultra sensitive genomics technology

Wim Van Criekinge, Co-Founder and Managing Director at Novalis_Linus Bosaeus, CEO at Rarity Bioscience

To further accelerate growth, Rarity Bioscience announces today a new strategicinvestment from Belgium based Novalis Biotech. The investment is facilitated as anoversubscription of the recent round closed in November 2022. Apart from previousowner, that round also included Wallenberg Investments through Navigare Venture,now bringing the total investment round to €3M. Novalis Biotech (Ghent, Belgium) is an […]